{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T11:23:38Z","timestamp":1730201018373,"version":"3.28.0"},"reference-count":15,"publisher":"IEEE","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1109\/bmei.2009.5305102","type":"proceedings-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T13:49:17Z","timestamp":1257428957000},"page":"1-5","source":"Crossref","is-referenced-by-count":1,"title":["Interphase FISH of Chromosome 1 and 13 in Newly Diagnosed Myeloma and the Disease Prognosis"],"prefix":"10.1109","author":[{"given":"Erming","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magne","family":"Borset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Barlogie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Shaughnessy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"263","reference":[{"key":"15","article-title":"A phase II multicenter study of the proteasome inhibitor bortezomib (VelcadeTM, formally PS-341) in multiple myeloma patients (pts) with relapsed\/refractory disease [abstract]","volume":"100","author":"richardson","year":"2002","journal-title":"Blood"},{"key":"13","first-page":"87","article-title":"Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma: IV. L-Phenylalanine mustard (NC-8806)","volume":"21","author":"bergsagel","year":"1962","journal-title":"Can Chem Rep"},{"doi-asserted-by":"publisher","key":"14","DOI":"10.1056\/NEJM199911183412102"},{"doi-asserted-by":"publisher","key":"11","DOI":"10.1002\/gcc.20109"},{"doi-asserted-by":"publisher","key":"12","DOI":"10.1182\/blood-2006-03-009910"},{"key":"3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0092-8674(00)81587-1","article-title":"Transposition by the RAG1 and RAG2 Proteins: A Possible Source of Oncogenic Translocations","volume":"94","author":"hiom","year":"1998","journal-title":"Cell"},{"key":"2","first-page":"92","article-title":"Comprehensive Geriatric","author":"balducci","year":"2004","journal-title":"Oncology"},{"year":"0","key":"1"},{"key":"10","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V96.4.1505","article-title":"High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH","volume":"96","author":"shaughnessy","year":"2000","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1182\/blood.V30.6.738.738","article-title":"Chromosomal Abnormalities in Multiple Myeloma","volume":"30","author":"das","year":"1967","journal-title":"Blood"},{"doi-asserted-by":"publisher","key":"6","DOI":"10.1016\/S0140-6736(59)90416-7"},{"doi-asserted-by":"publisher","key":"5","DOI":"10.1038\/85798"},{"year":"0","key":"4"},{"key":"9","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood.V86.11.4250.bloodjournal86114250","article-title":"Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities","volume":"86","author":"tricot","year":"1995","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood.V71.2.453.453","article-title":"Plasma cell Karyotype in Multiple Myeloma","volume":"71","author":"gould","year":"1988","journal-title":"Blood"}],"event":{"name":"2009 2nd International Conference on Biomedical Engineering and Informatics (BMEI)","start":{"date-parts":[[2009,10,17]]},"location":"Tianjin","end":{"date-parts":[[2009,10,19]]}},"container-title":["2009 2nd International Conference on Biomedical Engineering and Informatics"],"original-title":[],"link":[{"URL":"http:\/\/xplorestaging.ieee.org\/ielx5\/5301643\/5301644\/05305102.pdf?arnumber=5305102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:20:30Z","timestamp":1601054430000},"score":1,"resource":{"primary":{"URL":"https:\/\/ieeexplore.ieee.org\/document\/5305102\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":15,"URL":"https:\/\/doi.org\/10.1109\/bmei.2009.5305102","relation":{},"subject":[],"published":{"date-parts":[[2009,10]]}}}